skip to main
|
skip to sidebar
vioxx
Tuesday, December 8, 2009
FDA Advisory Committee -- Solo Slide
And, here it is:
Ahem -- Yawn. Background, here.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Followers
Blog Archive
▼
2009
(15)
▼
December
(13)
New Merck Names "The Fosamax Guy" As Its New Chief...
Pharmalot Has a Great Vioxx/Zetia Perspective Piec...
Fosamax "Bellweather Case" Trials: Updated Schedul...
A Pretty Comprehensive "Forward-Look" -- At New Merck
FDA Advisory Committee -- Solo Slide
Vertex Closes $442.8 Million Secondary Stock Offering
Sunday Evening: Food For Thought -- From TruthOut.Org
Pediatric Vytorin/Zetia Will Open Tuesday's FDA Ad...
Pediatric Vytorin FDA Packet -- Working Thread -- ...
On The "Gardasil Girls" Article, In The Cape Cod T...
Vertex To Use Goldman, Sachs To Raise At Least An ...
Phase III Result Favors Roche's Diabetes Drug Cand...
Bloomberg's -- And Tony Mauro's -- Takes On The "K...
►
November
(2)
About Me
steve
View my complete profile
No comments:
Post a Comment